Background The Xpert MTB/RIF assay is an automated molecular test that has improved the
detection of tuberculosis and rifampicin resistance, but its sensitivity is inadequate in …

Multidrug-resistant tuberculosis (MDR-TB), caused by drug-resistant strains of Mycobacterium
tuberculosis, is an increasingly serious problem worldwide. Here we examined a data set …

… Paired t test was used to determine mean difference in Ct values between groups that
showed successful virus growth on cell culture versus no growth. … The mean and median Ct …

Background Fluoroquinolones and second-line injectable drugs are the backbone of
treatment regimens for multidrug-resistant tuberculosis, and resistance to these drugs defines …

Background Repeated coronavirus disease 2019 (COVID-19) molecular testing can lead to
positive test results after negative results and to multiple positive results over time. The …

Background Symptom-based screening for tuberculosis is recommended for all people
living with HIV. This recommendation results in unnecessary Xpert MTB/RIF testing in many …

For Mycobacterium tuberculosis , phenotypic methods for drug susceptibility testing of
second-line drugs are poorly standardized and technically challenging. The Sensititre MYCOTB …

Objective: In settings of high HIV prevalence, tuberculosis control and patient management
are hindered by lack of accurate, rapid tuberculosis diagnostic tests that can be performed at …

Rationale: The recommended tuberculosis (TB) intensified case finding (ICF) algorithm for
people living with HIV (symptom-based screening followed by Xpert MTB/RIF [Xpert] testing) …

Repeat molecular testing for SARS-CoV-2 may result in scenarios including multiple positive
results, positive test results after negative tests, and repeated false negative results in …